Literature DB >> 27599107

THE SECOND BLIND SPOT: SMALL RETINAL VESSEL VASCULOPATHY AFTER VACCINATION AGAINST NEISSERIA MENINGITIDIS AND YELLOW FEVER.

Stavros N Moysidis1, Nicole Koulisis, Vivek R Patel, Amir H Kashani, Narsing A Rao, Mark S Humayun, Damien C Rodger.   

Abstract

PURPOSE: To describe a case of small retinal vessel vasculopathy postvaccination.
METHODS: We report the case of a 41-year-old white man who presented with a "second blind spot," describing a nasal scotoma in the right eye that started 4 days after vaccinations against Neisseria meningitidis and the yellow fever virus, and after a 2-month period of high stress and decreased sleep. Clinical examination, Humphrey visual field testing, and multimodal imaging with fundus photographs, autofluorescence, fluorescein angiography, and spectral domain optical coherence tomography and angiography were performed.
RESULTS: Clinical examination revealed a well-circumscribed, triangular area of retinal graying of about 1-disk diameter in size, located at the border of the temporal macula. This corresponded to a deep scotoma similar in size to the physiologic blind spot on Humphrey visual field 24-2 testing. There was mild hypoautofluoresence of this lesion on autofluorescence, hypofluorescence on fluorescein angiography, and focal attenuation of a small artery just distal to the bifurcation of an artery supplying the involved area. Spectral domain optical coherence tomography through the lesion conveyed hyperreflectivity most prominent in the inner and outer plexiform layers, with extension of the hyperreflectivity into the ganglion cell and inner nuclear layers. Spectral domain optical coherence tomography angiography demonstrated arteriolar and capillary dropout, more pronounced in the superficial retinal layer compared to the deeper retinal layer. At 1-month follow-up, his scotoma improved with monitoring, with reduction from -32 dB to -7 dB on Humphrey visual field testing. There was clinical resolution of the area of graying and decreased hyperreflectivity on spectral domain optical coherence tomography, with atrophy of the inner retina. Spectral domain optical coherence tomography angiography showed progression of arteriolar and capillary dropout, more so in the superficial than in the deep capillary plexus.
CONCLUSION: We describe a case of small artery occlusion in a previously healthy patient, 4 days after vaccination against N. meningitidis and yellow fever. Fluorescein angiography yielded greater diagnostic value than OCTA for evaluating the occlusion, whereas spectral domain optical coherence tomography angiography enabled better visualization of capillary dropout and layer-specific assessment. Further research is required to determine whether vaccination in general, or directed specifically at N. meningitidis or yellow fever, is associated with small vessel vasculopathy and the underlying pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27599107     DOI: 10.1097/ICB.0000000000000391

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  4 in total

Review 1.  Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

Authors:  Amir H Kashani; Chieh-Li Chen; Jin K Gahm; Fang Zheng; Grace M Richter; Philip J Rosenfeld; Yonggang Shi; Ruikang K Wang
Journal:  Prog Retin Eye Res       Date:  2017-07-29       Impact factor: 21.198

2.  Diffuse uveitis and chorioretinal changes after yellow fever vaccination: a re-emerging epidemic.

Authors:  Paula M Marinho; Heloisa Nascimento; Andre Romano; Cristina Muccioli; Rubens Belfort
Journal:  Int J Retina Vitreous       Date:  2019-10-07

3.  Paracentral acute middle maculopathy following hepatitis B vaccine.

Authors:  Verena R Juncal; Aditya Bansal; Hesham Hamli; Rajeev H Muni
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-11

4.  Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine.

Authors:  Nicholas Fowler; Noe R Mendez Martinez; Bernardo Velazquez Pallares; Ramiro S Maldonado
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.